Home›Stock Screener›Lactose

Lactose Share Price Today | Stock Price & Lactose Share Screener

LACTOSE Pharmaceuticals
Live Share Price BSE
₹106.95
▲ 1.55 (1.47%)
2026-10-05 00:00:00

As of October 5, 2026, the live Lactose share price (BSE: LACTOSE) is ₹106.95, up 1.47% from the previous close, with shares trading between ₹102.15 and ₹107.25 in today's trading session, and a 52-week range of ₹78.19–₹129.85. Check LACTOSE 52-week performance for the annual price range and momentum. Use the Lactose stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Lactose opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹172 and net income of ₹7, with EBITDA of ₹21, an operating margin of 11.0% and a profit margin of 4.1%.

Lactose Market Cap ₹132.72 Cr.
LACTOSE P/E Ratio (TTM) 19.47
Lactose P/B Ratio 2.31
EPS (TTM) ₹4.82
Dividend Yield -
Debt to Equity 0.97
LACTOSE 52 Week High ₹129.85
Lactose 52 Week Low ₹78.19
Operating Margin 11.00%
Profit Margin 4.07%
LACTOSE Revenue (TTM) ₹172.00
EBITDA ₹21.00
Net Income ₹7.00
Total Assets ₹183.00
Total Equity ₹65.00

Lactose Share Price Chart

Track the current stock price of Lactose with an interactive chart. Analyse LACTOSE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Lactose stock quote in one place.

The quote of ₹106.95 sits between the 52-week low of ₹78.19 and the 52-week high of ₹129.85, and the latest session moved 1.47% from the previous close.

Lactose Company Profile - Fundamental Screener

Screen Lactose company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LACTOSE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE058I01013.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE058I01013

Lactose Balance Sheet Screener

Screen LACTOSE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹183, up from ₹134 in 2025.

Latest statistics put total assets at ₹183 and shareholder funds at ₹65, with a leverage ratio of 0.97.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 183 134 101 101 90 88 84 82 83 85
Current Assets 99 57 36 37 23 20 20 18 17 18
Fixed Assets 69 52 55 56 59 60 62 60 63 64

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 29 30 28 34 36 42 38 35 38 31
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 65 59 47 41 39 35 34 34 32 27
Share Capital 13 13 13 13 13 11 10 10 10 10
Reserves & Surplus 46 40 35 28 27 23 24 24 21 17

Lactose Income Statement Screener - Profit & Revenue Analysis

Screen Lactose income statement and profit fundamentals. Analyze LACTOSE quarterly results. Lactose reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹172 and net profit was ₹7, equal to earnings per unit of ₹5.50, at an operating margin of 11%.

In that period expenses were ₹151, interest cost ₹6 and tax ₹2. The next period listed, 2026-March, shows revenue of ₹164 and net profit of ₹6.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 172 164 118 115 67 47 35 40 41 32 37 36 24
Expenses 151 145 99 95 54 34 29 31 31 26 24 24 19

Operating Costs and Margins

EBITDA 21 19 18 20 12 13 7 10 10 6 12 12 5
Operating Profit % 11.00% 11.00% 15.00% 17.00% 17.00% 27.00% 18.00% 23.00% 24.00% 18.00% 32.00% 30.00% 22.00%
Depreciation 6 6 5 5 5 5 4 4 4 4 3 3 2
Interest 6 5 6 5 6 5 5 6 5 6 5 4 3

Profit and Earnings

Profit Before Tax 10 9 7 10 2 3 -3 0 1 -3 4 4 1
Tax 2 3 2 3 0 1 -1 0 0 -1 2 1 0
Net Profit 7 6 5 7 1 3 -3 0 1 -1 3 3 1
EPS 5.50 4.82 4.10 5.39 0.96 2.10 -2.40 0.07 0.71 -1.37 2.88 3.30 0.60

Lactose Cash Flow Screener - Liquidity Fundamentals

Screen LACTOSE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹6, and net cash flow was an outflow of ₹4.

Over the same period, investing activities used ₹10 and financing activities provided ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 6 0 9 8 9 2 7 5 0 8
Investing Activities -10 -16 -2 -1 -1 -6 -3 -2 -2 -5

Financing and Net Cash

Financing Activities 1 19 -6 -8 -8 5 -4 -5 4 -3
Net Cash Flow -4 3 1 -1 0 1 1 -2 3 0

Lactose Shareholding Pattern Screener

See Lactose shareholding pattern with promoter, FII, and DII holdings. Check Lactose promoter holding and ownership changes for LACTOSE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 53.65%, foreign institutions 0.00%, domestic institutions 0.62% and the public 38.34%, spread across 16,554 shareholders.

The shareholder count was 16,554 in 2026-Jun, compared with 16,670 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 53.65% 53.65% 53.65% 53.65% 53.65% 53.65% 53.65% 53.65%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.34% 38.18% 38.07% 38.12% 38.24% 38.31% 38.08% 39.57%
Other Holding 7.40% 7.55% 7.67% 7.62% 7.50% 7.42% 7.65% 6.17%
Shareholder Count 16,554 16,670 16,770 16,810 17,013 17,082 17,115 16,998

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Lactose. Lactose dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Lactose.

Lactose Stock Index Membership - Nifty & Sensex

See which indices include Lactose stock. Check LACTOSE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Lactose is not part of any tracked indices.
Only major market indices are tracked in our system.

Lactose Market Events Screener - Corporate Actions

Get Lactose corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Lactose stock events that may affect LACTOSE share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 20, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-30 2026-09-30 Annual General Meeting NA -1.50%
2026-08-11 2026-08-11 Quarterly Result Announcement NA -1.23%
2026-05-20 2026-05-20 Quarterly Result Announcement NA 2.34%
2026-03-28 2026-03-28 Extraordinary General Meeting NA -19.52%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 4.09%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -5.35%
2025-09-30 2025-09-30 Annual General Meeting NA -4.46%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -0.29%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.58%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -9.38%
2024-11-15 2024-11-15 Extraordinary General Meeting NA -0.82%
2024-10-15 2024-10-15 Quarterly Result Announcement NA 13.21%
2024-09-30 2024-09-30 Annual General Meeting NA -5.03%

Lactose Competitors Screener - Peer Stocks Comparison

Screen LACTOSE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Lactose Company Announcements - News & Reports Screener

Screen LACTOSE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated October 4, 2026 and October 3, 2026.

Date Update Actions
2026-10-04 Disclosure Of Voting Results Of The Of 35Th Annual General Meeting Of Lactose India Limited (Company) Held On 30Th September 2026 -
2026-10-04 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-10-03 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-03 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-10-02 Closure of Trading Window -
2026-09-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Intimation For 35Th Annual General Meeting (AGM) Book Closure And Fixation Of Cut-Off Date For E-Voting Period Of Remote E-Voting For The Financial Year 2025-2026. -
2026-09-07 Shareholders Meeting - AGM On Wednesday 30Th September 2026 -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-09-05 Announcement under Regulation 30 (LODR)-Scheme of Arrangement -
2026-08-25 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-25 Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 25Th August 2026 -
2026-08-25 Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 25Th August 2026 -
2026-08-20 Announcement under Regulation 30 (LODR)-Scheme of Arrangement -
2026-08-20 Announcement Under Regulation 30 (LODR) -Scheme Of Amalgamation -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹106.95, within a 52-week range of ₹78.19 to ₹129.85. The P/E ratio is 19.47 and the P/B ratio is 2.31, with earnings per unit of ₹4.82. Market capitalisation stands at ₹132.72 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 7, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.